HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization
Nucleic Acids Research · 10.11.2023 · 51 (20) · e102-e102
DOI: 10.1093/nar/gkad790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 11.10.2023. Verfasst von Laurens Lambrechts und 9 weiteren Autor:innen. Beteiligte Einrichtung: HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium. Hauptthemen laut MEDLINE: HIV-1, Proviruses, Genome, Viral. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Research Foundation Flanders.
Abstract (Originalsprache)
A deep understanding of the composition of the HIV-1 reservoir is necessary for the development of targeted therapies and the evaluation of curative efforts. However, current near full-length (NFL) HIV-1 proviral genome sequencing assays are based on labor-intensive and costly principles of repeated PCRs at limiting dilution, restricting their scalability. To address this, we developed a high-throughput, long-read sequencing assay called HIV-PULSE (HIV Proviral UMI-mediated Long-read Sequencing). This assay uses unique molecular identifiers (UMIs) to tag individual HIV-1 genomes, allowing for the omission of the limiting dilution step and enabling long-range PCR amplification of many NFL genomes in a single PCR reaction, while simultaneously overcoming poor single-read accuracy. We optimized the assay using HIV-infected cell lines and then applied it to blood samples from 18 individuals living with HIV on antiretroviral therapy, yielding a total of 1308 distinct HIV-1 genomes. Benchmarking against the widely applied Full-Length Individual Proviral Sequencing assay revealed similar sensitivity (11 vs 18%) and overall good concordance, although at a significantly higher throughput. In conclusion, HIV-PULSE is a cost-efficient and scalable assay that allows for the characterization of the HIV-1 proviral landscape, making it an attractive method to study the HIV-1 reservoir composition and dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium.
- BioBix, Department of Data Analysis and Mathematical Modelling, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium.
- Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
ORCID-Profile: Laurens Lambrechts, Sofie Rutsaert, Filip Van Nieuwerburgh, Basiel Cole
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Research Foundation Flanders
- MSD
- Fonds voor Wetenschappelijk Onderzoek Vlaanderen
Zitieren
APA
Lambrechts, L., Bonine, N., Verstraeten, R., Pardons, M., Noppe, Y., Rutsaert, S., Van Nieuwerburgh, F., Van Criekinge, W., Cole, B., & Vandekerckhove, L. (2023). HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization. Nucleic Acids Research, 51(20), e102-e102. https://doi.org/10.1093/nar/gkad790
Vancouver
Lambrechts L, Bonine N, Verstraeten R, Pardons M, Noppe Y, Rutsaert S, et al. HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization. Nucleic Acids Research. 2023;51(20):e102-e102. doi:10.1093/nar/gkad790
BibTeX
@article{Lambrechts2023,
author = {Lambrechts, Laurens and Bonine, Noah and Verstraeten, Rita and Pardons, Marion and Noppe, Ytse and Rutsaert, Sofie and Van Nieuwerburgh, Filip and Van Criekinge, Wim and Cole, Basiel and Vandekerckhove, Linos},
title = {HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {20},
pages = {e102--e102},
doi = {10.1093/nar/gkad790}
}
EUVIMED